AGT and pulmonary arterial hypertension: In conclusion, our study demonstrated the therapeutic potential and mechanism of proteasome inhibition in Ang II‐ and PDGF‐BB‐induced dysregulation of PASMCs, shedding some lights in novel therapeutic strategies for PAH.